Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160


Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.

Colombo E, Banki K, Tatum AH, Daucher J, Ferrante P, Murray RS, Phillips PE, Perl A.

J Clin Invest. 1997 Mar 15;99(6):1238-50.


Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.

Banki K, Colombo E, Sia F, Halladay D, Mattson DH, Tatum AH, Massa PT, Phillips PE, Perl A.

J Exp Med. 1994 Nov 1;180(5):1649-63.


Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients.

Niland B, Miklossy G, Banki K, Biddison WE, Casciola-Rosen L, Rosen A, Martinvalet D, Lieberman J, Perl A.

J Immunol. 2010 Apr 1;184(7):4025-32. doi: 10.4049/jimmunol.0804174. Epub 2010 Mar 1.


[Epitopes on myelin proteins recognized by autoantibodies present in multiple sclerosis patients].

Jaśkiewicz E.

Postepy Hig Med Dosw (Online). 2004;58:472-82. Review. Polish.


Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis.

Johnson D, Hafler DA, Fallis RJ, Lees MB, Brady RO, Quarles RH, Weiner HL.

J Neuroimmunol. 1986 Nov;13(1):99-108.


T cell vaccination in multiple sclerosis patients with autologous CSF-derived activated T cells: results from a pilot study.

Van der Aa A, Hellings N, Medaer R, Gelin G, Palmers Y, Raus J, Stinissen P.

Clin Exp Immunol. 2003 Jan;131(1):155-68.


Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.

Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, Goebels N, Ertl B, Jechart G, Giegerich G, et al.

J Clin Invest. 1993 Dec;92(6):2633-43.


Evaluation of autoimmunity to transaldolase in multiple sclerosis.

Niland B, Perl A.

Methods Mol Med. 2004;102:155-71.


Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.

Belogurov AA Jr, Kurkova IN, Friboulet A, Thomas D, Misikov VK, Zakharova MY, Suchkov SV, Kotov SV, Alehin AI, Avalle B, Souslova EA, Morse HC 3rd, Gabibov AG, Ponomarenko NA.

J Immunol. 2008 Jan 15;180(2):1258-67.


Autoreactive T and B cells in nervous system diseases.

Sun JB.

Acta Neurol Scand Suppl. 1993;142:1-56.


HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.

Voskuhl RR, Robinson ED, Segal BM, Tranquill L, Camphausen K, Albert PS, Richert JR, McFarland HF.

J Immunol. 1994 Nov 15;153(10):4834-44.


Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK.

J Clin Invest. 1998 Feb 15;101(4):725-30. Erratum in: J Clin Invest 1998 Apr 1;101(7):1542.


T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.

Hellings N, Barée M, Verhoeven C, D'hooghe MB, Medaer R, Bernard CC, Raus J, Stinissen P.

J Neurosci Res. 2001 Feb 1;63(3):290-302.


T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis.

Söderström M, Link H, Sun JB, Fredrikson S, Kostulas V, Höjeberg B, Li BL, Olsson T.

Scand J Immunol. 1993 Mar;37(3):355-68.


Comparison of antibodies hydrolyzing myelin basic protein from the cerebrospinal fluid and serum of patients with multiple sclerosis.

Doronin VB, Parkhomenko TA, Castellazzi M, Padroni M, Pastore M, Buneva VN, Granieri E, Nevinsky GA.

PLoS One. 2014 Sep 29;9(9):e107807. doi: 10.1371/journal.pone.0107807. eCollection 2014.

Supplemental Content

Support Center